Prodyna 150 Mg & 300 Mg XR 150 mg, 300 mg Tablet
PDF Leaflet Revision Date: 15 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression as per DSM IV criteria.
Dosage (summary)
Initial: 150 mg once daily; may increase to 300 mg once daily after 24 hours if needed.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; avoid breastfeeding during treatment.
Key Drug Interactions
- CYP2B6 inhibitors
- CYP2D6 substrates
- MAOIs
Contraindications
- Hypersensitivity to bupropion
- Seizure disorder
- Patients under 18 years
- Bulimia or anorexia nervosa
- Severe hepatic cirrhosis
Common side effects
- Insomnia
- Agitation
- Dizziness
- Dry mouth
- Increased blood pressure
Counselling Points
- Monitor for worsening depression or suicidal thoughts.
- Avoid alcohol during treatment.
- Do not crush or chew tablets.
Serious warnings
- Risk of seizures
- Suicidal ideation in young adults
- Neuropsychiatric symptoms
Important Disclaimer
The Prodyna 150 Mg & 300 Mg XR 150 mg, 300 mg Tablet professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
